Investor FAQ

When was the company founded?

uniQure was founded in 1998 and was initially operated through our predecessor company, Amsterdam Molecular Therapeutics Holding N.V.

Where is the company incorporated?

We are incorporated under the laws of the Netherlands.

When did uniQure go public?

Our common stock began trading on February 5, 2014. The initial public offering price was US $17.00.

When is uniQure's fiscal year end?

Our fiscal year ends on December 31 of each year. Our fiscal quarters end on March 31, June 30, September 30 and December 31 of each year.

How is uniQure stock traded?

Our common stock is listed on the NASDAQ Global Market under the symbol QURE.

Who are uniQure's independent auditors?

KPMG Accountants N.V.
Laan van Langerhuize 1
1186 DS Amstelveen
The Netherlands
+31 20 656 78 90

Who is uniQure's legal counsel?

Jeannette Potts, Chief Legal Officer
1 Hartwell Ave., Lexington MA 02421

Where can I get the latest corporate news releases and financial reports?

uniQure’s press release archives can be viewed here.

Our financial reports are available here.

uniQure Logo Twitter Icon LinkedIn Icon YouTube Icon Twitter Icon Arrow Slideshow Next Button